HIG
60
-3
CCI
33
-5
O
35
-7
MDLZ
22
-2
PHM
55
-3
DVN
39
-4
ADP
62
-3
NOV
47
-6
LLY
68
-2
URBN
70
-4
HP
34
-7
ADM
44
-7
DGX
36
-4
TEL
72
-2
RCL
73
-3
TMO
50
-4
LMT
60
-2
KMI
53
-6
TJX
64
-2
NWS
52
4
HIG
60
-3
CCI
33
-5
O
35
-7
MDLZ
22
-2
PHM
55
-3
DVN
39
-4
ADP
62
-3
NOV
47
-6
LLY
68
-2
URBN
70
-4
HP
34
-7
ADM
44
-7
DGX
36
-4
TEL
72
-2
RCL
73
-3
TMO
50
-4
LMT
60
-2
KMI
53
-6
TJX
64
-2
NWS
52
4
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Nektar Therapeutics Industry Stock Comparison

Buy
59

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$4.98
Seasonality Move:
0.94%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Buy
59
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.00. The Score for JQC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $5.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JQC is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 38.68 Sell
Chaikin Money Flow: 242453 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5 - 5.1) Sell
Bollinger Bands (100): (5.06 - 5.46) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.04 Sell
20-day SMA: 5.04 Sell
50-day SMA: 5.08 Sell
200-day SMA: 5.29 Sell
8-day EMA: 5.04 Sell
20-day EMA: 5.05 Sell
50-day EMA: 5.11 Sell
200-day EMA: 5.3 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):